AcuFocus Raises $18 Million

AcuFocus Inc., an Irvine, Calif.-based maker of ocular implants to treat presbyopia, has raised $18 million in Series D funding from Bausch & Lomb. The deal was announced earlier this month without a price-tag, and also includes an option whereby B&L would purchase AcuFocus. The company previously had raised over $38 million in VC funding from firms like Versant Ventures, Three Arch Partners, SV Life Sciences, Pequot Capital, Carlyle Venture Partners and Accuitive Medical Ventures.